Sleep Disorders

An expert shares broad perspective on narcolepsy, discussing its causes, differences between types 1 and 2, and symptoms that may occur in patients.

Twelve months after subthalamic deep brain stimulation, patients with and without RBD had MDS-UPDRS IV score decrease, MDS-UPDRS III MedOff decrease, and total LEDD decrease, with no between group difference.

Data suggest the need to investigate sleep-disordered breathing even before lung function is compromised in patients with cystic fibrosis.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 5, 2021.

Expert clinicians offer their perspectives on the ongoing shortage of neurologists, stigmas associated with migraine, diets for those with epilepsy, mesenchymal stem cells in MS, and other topics.

Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive team.

Investigators interviewed 20 community neurologists about the impact of the pandemic on their professional and personal lives, finding 4 main themes among their responses.

The professor of neurology at Beth Israel Deaconess Medical Center discussed the treatment potential of melanin concentrating hormone receptor 1 antagonists for narcolepsy. [WATCH TIME: 3 minutes]

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 29, 2021.

Excessive daytime sleepiness is a hallmark of a number of sleep disorders, and ensuring the proper diagnosis and management of those presenting with it is crucial to care.

Here's what is coming soon to NeurologyLive.

In responding to complex cognitive tasks, the insomnia group had slower and more variable response latencies, produced fewer correct responses, and had more errors than normal sleepers.

Investigators found that stress was likely to be the most modifiable risk factor.

Neurology News Network for the week ending October 23, 2021. [WATCH TIME: 3 minutes]

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 22, 2021.

Data from a recent study suggest that symptoms of potential obstructive sleep apnea influence this mediation.

Findings from the phase 3 REST-ON trial of the investigational sodium oxybate formulation show treatment improves sleep latency response and cataplexy response in patients with narcolepsy.

Patients with chronic insomnia were included in the study to understand whether priming is necessary for partial reinforcement of treatment responses.

The authors noted that the CBT-acupressure approach may serve particularly well for individuals whose cultural values align with traditional Chinese medicine approaches.

Here's what is coming soon to NeurologyLive.

Action is not anticipated to be taken this month, with a new target action date to be provided.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 15, 2021.

A large-scale rural population study included approximately 27,935 men and women, finding that sleep quality might predict risk of coronary heart disease.

Here's what is coming soon to NeurologyLive.

Investigators used the Baveno classification to group patients at diagnosis of obstructive sleep apnea and again after 5 years.

The division chief of vascular neurology at the University of Utah discussed the individual role that clinicians and neurologists can play to increase interest in the field of neurology. [WATCH TIME: 2 minutes]

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 8, 2021.

Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive team.